A 73-year-old woman is brought to the emergency department due to a 4-day history of progressively worsening shortness of breath and an increase in the volume and purulence of her sputum. Her medical history includes severe chronic obstructive pulmonary disease (COPD) and ischemic cardiomyopathy with a left ventricular ejection fraction of 35%.
Vital signs are temperature 38.1°C (100.6°F), blood pressure 146/88 mmHg, pulse 112/min, and respirations 28/min. Pulse oximetry shows 87% on room air.
Physical examination shows a patient in respiratory distress using accessory muscles. Jugular venous pressure is estimated at 7 cm H2O. Chest auscultation reveals a prolonged expiratory phase with diffuse polyphonic wheezing. There is no lower extremity edema.
Laboratory studies show:
Leukocyte count: 14,200/mm³
B-type natriuretic peptide: 85 pg/mL
Arterial blood gas (room air):
pH: 7.26
PaCO2: 68 mmHg
PaO2: 50 mmHg
HCO3-: 30 mEq/L
A sputum Gram stain reveals numerous polymorphonuclear leukocytes and gram-negative coccobacilli. She is promptly started on noninvasive positive-pressure ventilation, nebulized ipratropium-albuterol, and intravenous methylprednisolone.
Which of the following is the most appropriate additional pharmacologic intervention for this patient?
- Oral azithromycinAnswer
- BIntravenous vancomycin and piperacillin-tazobactam
- CIntravenous furosemide
- DIntravenous sodium bicarbonate
- EIntravenous metoprolol